000 01589 a2200421 4500
005 20250515073545.0
264 0 _c20071019
008 200710s 0 0 eng d
022 _a1615-9853
024 7 _a10.1002/pmic.200700108
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchumacher, Jonathan A
245 0 0 _aProteome-wide changes induced by the Hsp90 inhibitor, geldanamycin in anaplastic large cell lymphoma cells.
_h[electronic resource]
260 _bProteomics
_cAug 2007
300 _a2603-16 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntibiotics, Antineoplastic
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aBenzoquinones
_xpharmacology
650 0 4 _aCaspase 3
_xmetabolism
650 0 4 _aCell Cycle
_xdrug effects
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aDNA, Neoplasm
_xanalysis
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aHSP90 Heat-Shock Proteins
_xantagonists & inhibitors
650 0 4 _aHumans
650 0 4 _aLactams, Macrocyclic
_xpharmacology
650 0 4 _aLymphoma, Large B-Cell, Diffuse
_xenzymology
650 0 4 _aModels, Biological
650 0 4 _aProteome
_xanalysis
650 0 4 _aReproducibility of Results
700 1 _aCrockett, David K
700 1 _aElenitoba-Johnson, Kojo S J
700 1 _aLim, Megan S
773 0 _tProteomics
_gvol. 7
_gno. 15
_gp. 2603-16
856 4 0 _uhttps://doi.org/10.1002/pmic.200700108
_zAvailable from publisher's website
999 _c17146240
_d17146240